Real‐world prognostic factors for survival among treated patients with metastatic pancreatic ductal adenocarcinoma

BACKGROUND: Many real‐world studies of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) are restricted to single centers, limiting the generalizability of their insights. This study aimed to identify important population‐based predictors for survival in patients diagnosed with mPDAC...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Kenneth H., Ozer, Muhammet, Cockrum, Paul, Surinach, Andy, Wang, Shu, Chu, Bong Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683530/
https://www.ncbi.nlm.nih.gov/pubmed/34811961
http://dx.doi.org/10.1002/cam4.4415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683530/
https://www.ncbi.nlm.nih.gov/pubmed/34811961
http://dx.doi.org/10.1002/cam4.4415

Ejemplares similares